These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37685852)

  • 41. Targeted therapeutic effects of oral inulin-modified double-layered nanoparticles containing chemotherapeutics on orthotopic colon cancer.
    Hou Y; Jin J; Duan H; Liu C; Chen L; Huang W; Gao Z; Jin M
    Biomaterials; 2022 Apr; 283():121440. PubMed ID: 35245731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In situ dual-crosslinked nanoparticles for tumor targeting gene delivery.
    Zhang Y; Liu L; Lin L; Chen J; Tian H; Chen X; Maruyama A
    Acta Biomater; 2018 Jan; 65():349-362. PubMed ID: 28663142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of surface functionalized hydroxyapatite nanoparticles for enhanced specificity towards tumor cells.
    Verma G; Shetake NG; Pandrekar S; Pandey BN; Hassan PA; Priyadarsini KI
    Eur J Pharm Sci; 2020 Mar; 144():105206. PubMed ID: 31870813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dual-ligand α
    Levine RM; Kokkoli E
    J Control Release; 2017 Apr; 251():24-36. PubMed ID: 28215671
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.
    Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G
    Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dual targeting of Mg/N doped-carbon quantum dots with folic and hyaluronic acid for targeted drug delivery and cell imaging.
    Ziaee N; Farhadian N; Abnous K; Matin MM; Khoshnood A; Yaghoobi E
    Biomed Pharmacother; 2023 Aug; 164():114971. PubMed ID: 37295246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
    Sargazi A; Shiri F; Keikha S; Majd MH
    Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
    Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
    Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
    Kumar P; Tambe P; Paknikar KM; Gajbhiye V
    Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity.
    Dong Z; Wang Y; Guo J; Tian C; Pan W; Wang H; Yan J
    Drug Des Devel Ther; 2022; 16():2683-2693. PubMed ID: 35983428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery.
    Tsolou A; Angelou E; Didaskalou S; Bikiaris D; Avgoustakis K; Agianian B; Koffa MD
    Int J Nanomedicine; 2020; 15():4899-4918. PubMed ID: 32764924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative control of active targeting of nanocarriers to tumor cells through optimization of folate ligand density.
    Tang Z; Li D; Sun H; Guo X; Chen Y; Zhou S
    Biomaterials; 2014 Sep; 35(27):8015-27. PubMed ID: 24947231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surface Presentation of Hyaluronic Acid Modulates Nanoparticle-Cell Association.
    Deiss-Yehiely E; Brucks SD; Boehnke N; Pickering AJ; Kiessling LL; Hammond PT
    Bioconjug Chem; 2022 Nov; 33(11):2065-2075. PubMed ID: 36282941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Folate decorated lipid chitosan hybrid nanoparticles of 5-fluorouracil for enhanced anticancer efficacy against colon cancer.
    Khan S; Madni A; Shah H; Jan N; Shafiq A; Basit A; Rai N; Ali A; Khan MM
    Int J Biol Macromol; 2022 Dec; 222(Pt A):497-508. PubMed ID: 36174854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigation of folate-conjugated fluorescent silica nanoparticles for targeting delivery to folate receptor-positive tumors and their internalization mechanism.
    Yang H; Lou C; Xu M; Wu C; Miyoshi H; Liu Y
    Int J Nanomedicine; 2011; 6():2023-32. PubMed ID: 21976977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dual targeting biomimetic liposomes for paclitaxel/DNA combination cancer treatment.
    Liu GX; Fang GQ; Xu W
    Int J Mol Sci; 2014 Aug; 15(9):15287-303. PubMed ID: 25177862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
    Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H
    J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Folic Acid-Functionalized Nanomedicine: Folic Acid Conjugated Copolymer and Folate Receptor Interactions Disrupt Receptor Functionality Resulting in Dual Therapeutic Anti-Cancer Potential in Breast and Prostate Cancer.
    DeCarlo A; Malardier-Jugroot C; Szewczuk MR
    Bioconjug Chem; 2021 Mar; 32(3):512-522. PubMed ID: 33556240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel.
    Muntimadugu E; Kumar R; Saladi S; Rafeeqi TA; Khan W
    Colloids Surf B Biointerfaces; 2016 Jul; 143():532-546. PubMed ID: 27045981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dual-targeted and controlled release delivery of doxorubicin to breast adenocarcinoma: In vitro and in vivo studies.
    Jamshidi Z; Sadat Zavvar T; Ramezani M; Alibolandi M; Hadizadeh F; Abnous K; Taghdisi SM
    Int J Pharm; 2022 Jul; 623():121892. PubMed ID: 35671850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.